HDFCCC Newsletter
UCSF Receives $20 Million to Study New Tobacco Products
UC San Francisco has been awarded a five-year, $20 million grant from the U.S. Food and Drug Administration and the National Institutes of Health to study the impacts of new and emerging tobacco products, including e-cigarettes and heated tobacco products (HTPs), which heat tobacco without combustion. UCSF is one of nine institutions nationally to receive funding this year from the Tobacco Centers of Regulatory Science (TCORS). [read more]
news Mike Rabow, MD, Reflects on the HDFCCC Symptom Management Service
In 13 years, the specialty palliative care program has grown into one of largest in the country and serves as a national model. In this Q&A, Rabow discusses palliative care at UCSF and efforts to integrate it earlier into treatment for cancer patients.
news Biden Cancer Community Summits Held Nationwide
On September 21, Vice President Joe Biden and Dr. Jill Biden, along with local organizations around the country, will host cancer summits focused on improving the cancer journey for patients, their families, and caregivers. Attend in person or watch online.
  UCSF will be holding free drop-in flu shot clinics for all employees, students, and volunteers through October 12th at various locations.

Getting vaccinated protects not only you, but those around you.

> flu shot clinic schedule and locations

Awards & Distinctions
Valerie Weaver, PhD was recently awarded the Worldwide Cancer Research Colin Thomson Memorial Medal for outstanding cancer research. Read more.
Elad Ziv, MD received a grant of $3.3M over 5 years from the National Cancer Institute for his project, "Genetics of immune related adverse events and response to immunotherapy."
Michelle Arkin, PhD received the 2018 Breakthrough Science Initiative Award from the Ono Pharma Foundation to study a class of proteins, called 14-3-3 proteins, known to be involved in various cancers. Read more.
Lawrence Fong, MD and Eliezer Van Allen, MD (Dana-Farber Cancer Institute) were awarded an NCI U01 associated with the Beau Biden Cancer Moonshot Initiative. Their project is entitled, "Molecular and immune drivers of immunotherapy responsiveness in prostate cancer."
Katie Kelley, MD, along with investigators from the NCI and seven other institutions, is an Associate Investigator on a new Liver Cancer Moonshot Study. The project is entitled, "A National Translational Science Network of Precision-based Immunotherapy for Liver Cancer."
Valerie Weaver, PhD received an award in the amount of $250,000 from the Breast Cancer Research Foundation for her project, "Potentiating the stress amplification response to overcome treatment resistant metastatic breast cancer."
Hala Borno, MD received a PCF Young Investigator Award for her project, "Leveraging health information technology to understand and address disparities in prostate cancer clinical trial participation."
David Oh, MD, PhD received a PCF Young Investigator Award for his project, "Single Cell Discrimination of Immunotherapy-Induced Changes in the Prostate Tumor Microenvironment."
Hui Li, PhD received a PCF Young Investigator Award for his project, "Interrogating the Role of SChLAP1-AS in Prostate Cancer Progression."
Rohit Bose, MD, PhD received a K08 grant over 5 years from the National Cancer Institute for his project, "Investigating How a Balance of Negative and Positive ETS Factors Controls Prostate Oncogenesis."
Philip Rosenthal, MD received a grant of $3.5M over 5 years from the National Institute of Allergy & Infectious Diseases for a project, "Mechanisms of varied sensitivity of P. falciparum field isolates to the antimalarial drug pipeline."
Kim F. Rhoads, MD, MS, MPH, FACS became an affiliated faculty member of the Philip R. Lee Institute for Health Policy Studies (PRL-IHPS).
In the News
news New Approach to Breast Reconstruction May Reduce Pain and Weakness for Some
New York Times | Sep 17, 2018
news I-SPY 2 Revolutionizing the Treatment of Early Stage, High-Risk Breast Cancer
I-SPY Trials | Sep 12, 2018
news Researchers Unlock Secret of Deadly Brain Cancer's "Immortality"
UCSF | Sep 10, 2018
news Mutations, Drugs Drive Cancer by Blurring Growth Signals
UCSF | Sep 6, 2018
news Tailored Drug Cocktails Offer Hope to Kids with Aggressive Brain Tumors
UCSF | Aug 29, 2018
news Chronic Inflammation Can Trigger Cancers Via Newly Discovered Mechanism
UCSF | Aug 23, 2018
Recent Publications

Choi S, Yu Y, Grimmer MR, Wahl M, Chang SM, Costello JF. Temozolomide-associated hypermutation in gliomas. Neuro Oncol. 2018 Sep 3;20(10):1300-1309.

Eckhardt M, Zhang W, Gross AM, Von Dollen J, Johnson JR, Franks-Skiba KE, Swaney DL, Johnson TL, Jang GM, Shah PS, Brand TM, Archambault J, Kreisberg JF, Grandis JR, Ideker T, Krogan NJ. Multiple Routes to Oncogenesis are Promoted by the Human Papillomavirus-Host Protein Network. Cancer Discov. 2018 Sep 12.

Tang V, Zhao S, Boscardin J, Sudore R, Covinsky K, Walter LC, Esserman L, Mukhtar R, Finlayson E. Functional Status and Survival After Breast Cancer Surgery in Nursing Home Residents. JAMA Surg. 2018 Aug 29.

Collisson EA. Bringing Pancreas Cancer into the Lab. Cancer Discov. 2018 Sep;8(9):1062-1063.

Barnes JM, Kaushik S, Bainer RO, Sa JK, Woods EC, Kai F, Przybyla L, Lee M, Lee HW, Tung JC, Maller O, Barrett AS, Lu KV, Lakins JN, Hansen KC, Obernier K, Alvarez-Buylla A, Bergers G, Phillips JJ, Nam DH, Bertozzi CR, Weaver VM. A tension-mediated glycocalyx-integrin feedback loop promotes mesenchymal-like glioblastoma. Nat Cell Biol. 2018 Sep 10.

From HDFCCC Communications
  news Wondering how to promote an event, publication, or funding opportunity to the UCSF cancer community?

Learn about our Cancer Center newsletters (like this one!) — including who receives them, what information is included, and how to submit content.
Sep 18: Greater Bay Area Cancer Registry Symposium - UCSF Mission Bay
Keynote presentation by Lynne Penberthy, MD, MPH, Associate Director, Surveillance Research Program, Div. of Cancer Control and Population Sciences, NCI.
Sep 19: Breast Oncology Program Seminar Series - UCSF Mount Zion
Laura Esserman, MD, MBA, and Laura van 't Veer, PhD, will present on "ISPY2 Program Update: New drugs and new biomarkers."
Sep 21: Geriatric Oncology Symposium - UCSF Mission Bay
This event will highlight geriatric oncology research at UCSF and foster new multidisciplinary collaborations.
Sep 27: The BRCA Gene: An Evening of Education on the Latest Research - Sherith Israel
An informative community-wide event for women and men to join in a conversation about the BRCA gene mutation.
Sep 29: AIM Living With Melanoma Symposium at UCSF - UCSF Mission Bay
AIM's Living With Melanoma Symposiums bring together leading medical and wellness professionals with people affected by melanoma to learn, connect, and share.
Employment and Training
Tissue Acquisition Research Associate II, Helen Diller Family Comprehensive Cancer Center, UCSF
Data Scientist, Department of Neurosurgery, UCSF
View open positions at Rohit Bose Lab, UCSF
View opportunities from QB3 startups
  UNSUBSCRIBE | ABOUT | CONTACT facebook twitter